A study to evaluate the safety and efficacy of PTC518 in participants with Huntington's disease (HD)
PIVOT HD · PTC Therapeutics International Limited
Phase 2 study testing PTC518 to see whether it can slow the progression of Huntington's disease.
Recruitment endedPhase 2Not specifiedISRCTNTreatment trial
Recruiting in: United StatesExact site not listed by the study registry.
Preparing a short plain-English summary.
